Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
01/16/2003 | WO2002087759B1 Polymer-bound catalyst for the enantioselective aldol or mannich reaction |
01/16/2003 | WO2002041984A3 Catalytic compositions and methods for asymmetric aldol reactions |
01/16/2003 | US20030013894 Comprises conversion of oxalamide to dithiooxalamide, followed by conversion of the dithiooxalamide to either a 4,5-bisimino-(1,3)dithiolane or 2,3-bisimino-(1,4)dithiane |
01/16/2003 | US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
01/16/2003 | US20030013847 Pyruvate derivatives |
01/16/2003 | US20030013846 Cytoprotective agents |
01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
01/16/2003 | US20030013754 Antiinflamamtory agents |
01/16/2003 | US20030013741 Antihistamines; antiallergens |
01/16/2003 | US20030013725 Amino acid derivatives |
01/16/2003 | US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents |
01/16/2003 | US20030013700 Thrombin inhibitors |
01/16/2003 | US20030013677 Anticancer agents |
01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
01/16/2003 | US20030013603 Catalyst for oxidation, carbonylation, nitration, sulfonation |
01/16/2003 | US20030009835 Comprises oxidation base such as 1-N,N-bis(3',4'-dihydroxybutyl)-para-phenylenediamine; oxidative hair color dyes |
01/16/2003 | CA2521993A1 Crystalline forms of ¬r-(r*,r*)|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-¬(phenylamino)carbonyl|-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
01/16/2003 | CA2453211A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation |
01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
01/16/2003 | CA2451159A1 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives |
01/16/2003 | CA2450857A1 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
01/16/2003 | CA2448917A1 Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof |
01/15/2003 | EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
01/15/2003 | EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides |
01/15/2003 | EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
01/15/2003 | EP1274678A1 Novel alpha-sulfin- and alpha-sulfonamido acid amides |
01/15/2003 | EP1274423A1 Medicine for treating traumatic brain injury and other neuronal disorders |
01/15/2003 | EP0889031B1 Simple process for producing high-quality captopril |
01/15/2003 | EP0862571B1 Herbicidal sulfonamides |
01/15/2003 | EP0820451B1 Novel heterocyclic compounds |
01/15/2003 | EP0713483B1 Amidine derivatives with nitric oxide synthetase activities |
01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
01/15/2003 | CN1390833A 2,5-cis-bisubstituted pyrrolidine derivative and its preparing process and usage |
01/15/2003 | CN1098849C 噻唑衍生物 Thiazole derivatives |
01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
01/14/2003 | US6506906 Preparation and use of bifunctional molecules having DNA sequence binding specificity |
01/14/2003 | US6506894 Solution phase synthesis of oligonucleotides |
01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
01/14/2003 | US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of |
01/14/2003 | US6506788 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
01/14/2003 | US6506759 Retroviral protease inhibitors |
01/14/2003 | US6506517 Surface modified carbonaceous materials |
01/14/2003 | US6506459 Coating compositions containing alkoxy substituted perfluoro compounds |
01/09/2003 | WO2003002596A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
01/09/2003 | WO2003002595A2 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
01/09/2003 | WO2003002553A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
01/09/2003 | WO2003002522A1 Peptide deformylase inhibitors |
01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
01/09/2003 | WO2003002491A2 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
01/09/2003 | WO2002062777A9 Amino ceramide-like compounds and therapeutic methods of use |
01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
01/09/2003 | US20030009056 Process for the removal of nitrobenzenesulfonyl |
01/09/2003 | US20030009032 For inhibiting the replication or infectivity of a virus; therapy |
01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
01/09/2003 | US20030008910 Use of proteasome inhibitors to treat dry eye disorders |
01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
01/09/2003 | US20030008874 1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists |
01/09/2003 | CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
01/09/2003 | CA2424645A1 New use of dipeptidyl peptidase iv inhibitors |
01/09/2003 | CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
01/08/2003 | EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same |
01/08/2003 | EP1272567A2 Mono- and bis-hydrazone pigments |
01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
01/08/2003 | EP1272178A2 Bilirubin or biliverdin degradation fragments |
01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
01/08/2003 | EP1242521A4 Recovery of modifier compounds and polar organic compounds from a poly(arylene sulfide) recycle mixture |
01/08/2003 | EP1124819B1 Method of lithiating five-membered heterocycles |
01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
01/08/2003 | EP0915881B1 Pyrroloazepine compounds |
01/08/2003 | CN1389459A Optical breaking process of d1-trans-4-phenyl-5-O-chlorobenzyl pyrrolidone-2 |
01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
01/03/2003 | WO2003000647A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
01/03/2003 | WO2003000249A1 Function regulator for retinoid relative receptor |
01/03/2003 | WO2003000198A2 Selective neuronal nitric oxide synthase inhibitors |
01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
01/03/2003 | CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
01/03/2003 | CA2449441A1 3-fluoro-pyrrolidines as antidiabetic agents |
01/02/2003 | US20030004337 Efficient lactam synthesis |
01/02/2003 | US20030004308 Anticoagulants |
01/02/2003 | US20030004208 Squalene synthetase inhibitors; antilipemic agents, anticholesterol agents |
01/02/2003 | US20030004186 Anticoagulants; cardiovascular disorders; central nervous system disorders |
01/02/2003 | US20030004138 Hypoglycemic agents; antidiabetic agents; dietetics |
01/02/2003 | EP1270562A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof |
01/02/2003 | EP1268455A2 Piperazine derivatives |
01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
01/02/2003 | EP1268453A1 Estrogen agonist/antagonist metabolites |
01/02/2003 | EP1268420A1 Chemokine receptor antagonists |
01/02/2003 | EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors |
01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |